Growth Metrics

Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Other Non-Current Liabilities readings, the most recent being $4.4 billion for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 11.33% to $4.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.4 billion, a 11.33% increase, with the full-year FY2025 number at $4.3 billion, up 7.12% from a year prior.
  • Other Non-Current Liabilities hit $4.4 billion in Q1 2026 for Thermo Fisher Scientific, up from $4.3 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.7 billion in Q2 2022 to a low of $4.0 billion in Q1 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $4.3 billion (2023), compared with a mean of $4.3 billion.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 39.14% in 2022 and later decreased 14.07% in 2024.
  • Thermo Fisher Scientific's Other Non-Current Liabilities stood at $4.2 billion in 2022, then increased by 9.53% to $4.6 billion in 2023, then dropped by 14.07% to $4.0 billion in 2024, then grew by 7.12% to $4.3 billion in 2025, then increased by 3.46% to $4.4 billion in 2026.
  • The last three reported values for Other Non-Current Liabilities were $4.4 billion (Q1 2026), $4.3 billion (Q4 2025), and $4.3 billion (Q3 2025) per Business Quant data.